Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sex Differences in Cannabis Use and Stress
NCT05885542Phase 2Recruiting
- Sponsor
- Medical University of South Carolina
- Start
- Nov 2023
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cannabis use disorder (CUD) comparing Cannabidiol with Placebo (2 arms). Primary endpoints: Cannabis withdrawal symptoms at 3 days, Stress reactivity and 1 more. Started Nov 2023; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT05885542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05885542.